Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CRVS

Corvus Pharmaceuticals, Inc.

CIK 0001626971 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$14.46
↑ 0.13 (0.91%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$1.22B
P/E Ratio
-22.47
EPS
-0.19
Dividend Yield
Not covered
52W Position
43%
Beta
-0.50

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
5.40
P/S
Not covered
EV/Revenue
Not covered
ROE
-24.0%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 43%
$5.03$26.95

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$15.28M
Total Assets
$71.12M
Free Cash Flow
-$32.97M

Recent news